AIG hospitals
Hyderabad, Telangana, 500082, India
Location status: Recruiting
Location contact
AIG hospitals
CONTACT
Aniruddha Pratap Singh, MBBS, MD, DM
PRINCIPAL_INVESTIGATOR
Koduri Krithi Krishna, MBBS, MD, DNB
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06928350
This study aims to determine normal 24-hour pH-impedance monitoring values, including acid exposure time (AET), in healthy Indian adults. It will help improve GERD diagnosis in India by providing population-specific data. The study will also explore how diet, body position, and nighttime reflux affect acid exposure. Healthy volunteers aged 18 and above will be monitored for 24 hours.
Interested in participating?
Request Info18 year–50 year
All sexes
Observational
Hyderabad, Telangana, 500082, India
Location status: Recruiting
AIG hospitals
CONTACT
Aniruddha Pratap Singh, MBBS, MD, DM
PRINCIPAL_INVESTIGATOR
Koduri Krithi Krishna, MBBS, MD, DNB
PRINCIPAL_INVESTIGATOR
This prospective study aims to establish normal 24-hour ambulatory pH-impedance monitoring values, including acid exposure time (AET), in healthy Indian volunteers. With an estimated GERD prevalence of 8-10% in India, current diagnostic criteria, such as the Lyon Consensus cut-off of 6%, may not be suitable for the Indian population due to differences in AET. The study will investigate the normative values of AET in healthy individuals and examine how factors such as diet, body position, and nocturnal reflux influence acid exposure and reflux episodes. By determining these standard values, the study seeks to enhance the accuracy of GERD diagnosis in India and improve understanding of reflux patterns specific to the Indian population. Participants will be healthy adults aged 18 and above, without gastrointestinal symptoms or major systemic diseases. The study will be conducted as a single-centre, 24-hour monitoring protocol.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: The primary outcome measures include the percentage of time the esophageal pH is below 4 (acid exposure time) and the total number of reflux episodes detected by impedance monitoring in both proximal and distal channels, assessed over a 24-hour monitorin
The primary outcome measures include the percentage of time the esophageal pH is below 4 (acid exposure time) and the total number of reflux episodes detected by impedance monitoring in both proximal and distal channels, assessed over a 24-hour monitoring period.
Contact information is provided by the study sponsor or research team.
Krithi Krishna Doctor
CONTACT
Musfira Kauser
CONTACT
Asian Institute of Gastroenterology, India
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07624383
Deglutition Disorders, Digestive System Diseases
Warsaw, Masovian Voivodeship, Poland
View Trial DetailsNCT07678177
Deglutition Disorders, Digestive System Diseases
Seoul, South Korea
View Trial DetailsNCT06613438
Deglutition Disorders, Digestive System Diseases
Chicago, Illinois, United States
View Trial DetailsNCT07125521
Behavior, Deglutition Disorders
Hanoi, Vietnam
View Trial Details